NCTN: A Randomized Phase III Post-operative Trial of Platinum Based Chemotherapy vs. Capecitabine in Patients with Residual Triple-Negative Basal-Like Breast Cancer following Neoadjuvant Chemotherapy (EA1131)
Getting access
No access information recorded yet.
About this database
| Last updated | 2026-08-25 |
|---|